Clinical and Epidemiological Features In Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, pp.29-86, 1999. ,
Neurofibromatosis Type 1: Molecular and Cellular Biology, 2012. ,
DOI : 10.1007/978-3-642-32864-0
Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1, The Journal of Pediatrics, vol.149, issue.3, pp.348-353, 2006. ,
DOI : 10.1016/j.jpeds.2006.04.025
Cognitive Function and Academic Performance, Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, p.380, 1999. ,
The Cognitive Profile of NF1 Children: Therapeutic Implications, In Neurofibromatosis Type Molecular and Cellular Biology, vol.1, issue.2012, p.55 ,
DOI : 10.1007/978-3-642-32864-0_5
The Impact of ADHD on the Cognitive and Academic Functioning of Children With NF1, Developmental Neuropsychology, vol.6, issue.7, pp.590-600, 2012. ,
DOI : 10.1016/S0140-6736(10)61109-9
The Diagnosis of Neurofibromatosis-1 in the Child Under the Age of 6 Years, Archives of Pediatrics & Adolescent Medicine, vol.143, issue.6, pp.717-719, 1989. ,
DOI : 10.1001/archpedi.1989.02150180099028
The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2, JAMA: The Journal of the American Medical Association, vol.278, issue.1, pp.51-57, 1997. ,
DOI : 10.1001/jama.1997.03550010065042
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1, Neurology, vol.65, issue.7, pp.1037-1044, 2005. ,
DOI : 10.1212/01.wnl.0000179303.72345.ce
Neuropsychological Profile of Children With Neurofibromatosis, Brain Tamor, or Both, Journal of Child Neurology, vol.9, issue.4, pp.368-377, 1994. ,
DOI : 10.1177/088307389400900406
Intellectual impairment in neurofibromatosis 1, Journal of the Neurological Sciences, vol.138, issue.1-2, pp.125-133, 1996. ,
DOI : 10.1016/0022-510X(96)00022-6
Children and Adolescents with Neurofibromatosis 1, Journal of Developmental & Behavioral Pediatrics, vol.17, issue.4, pp.229-239, 1996. ,
DOI : 10.1097/00004703-199608000-00004
Social and emotional problems in children with neurofibromatosis type 1: Evidence and proposed interventions, The Journal of Pediatrics, vol.134, issue.6, pp.767-772, 1999. ,
DOI : 10.1016/S0022-3476(99)70296-9
Treatment of ADHD in neurofibromatosis type 1, Developmental Medicine & Child Neurology, vol.98, issue.Suppl. 5, pp.164-170, 2002. ,
DOI : 10.1111/j.1469-8749.2002.tb00780.x
Behavioral phenotype of neurofibromatosis, type 1, Mental Retardation and Developmental Disabilities Research Reviews, vol.37, issue.2, pp.117-124, 2000. ,
DOI : 10.1002/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X
Early Grade Repetition and Inattention Associated With Neurofibromatosis Type 1, Journal of Attention Disorders, vol.11, issue.2, pp.101-105, 2007. ,
DOI : 10.1177/1087054707299398
The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1, Developmental Medicine & Child Neurology, vol.31, issue.10, pp.892-899 ,
DOI : 10.1111/j.1469-8749.2012.04377.x
Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate, Current Neuropharmacology, vol.6, issue.4, pp.322-328, 2008. ,
DOI : 10.2174/157015908787386069
Methylphenidate in children with hyperactivity: review and cost-utility analysis, Pharmacoepidemiology and Drug Safety, vol.34, issue.2, pp.85-94, 2001. ,
DOI : 10.1002/pds.564
How efficacious and safe is short-acting methylphenidate for the treatment of attentiondeficit disorder in children and adolescents? A meta-analysis, CMAJ, vol.165, pp.1475-1488, 2001. ,
Attention-Deficit Hyperactivity Disorder: Critical Appraisal of Extended Treatment Studies, The Canadian Journal of Psychiatry, vol.347, issue.2, pp.337-348, 2002. ,
DOI : 10.1001/jama.1995.03520290060030
A Double-Blind, Placebo-Controlled Study of Modified-Release Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder, PEDIATRICS, vol.109, issue.3, p.39, 2002. ,
DOI : 10.1542/peds.109.3.e39
Compliance With Pharmacological and Cognitive Treatments for Attention Deficit Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, vol.26, issue.4, pp.521-526, 1987. ,
DOI : 10.1097/00004583-198707000-00010
Stimulant Treatment Over Five Years: Adherence, Effectiveness, and Adverse Effects, Journal of the American Academy of Child & Adolescent Psychiatry, vol.43, issue.5, pp.559-567, 2004. ,
DOI : 10.1097/00004583-200405000-00009
Quality of Life Assessment in Clinical Trials: Methods and Practice, 1998. ,
Rank transformations as a bridge between parametric and nonparametric statistics, Am Stat, vol.35, pp.124-129, 1981. ,
Manual for the Strait-Trait Anxiety Inventory for Children, Book Manual for the Strait-Trait Anxiety Inventory for Children, 1973. ,
Increased methylphenidate usage for attention deficit disorder in the 1990s, Pediatrics, vol.98, pp.1084-1088, 1996. ,
Paediatric methylphenidate (Ritalin??) restrictive conditions of prescription in France, British Journal of Clinical Pharmacology, vol.37, issue.1, pp.115-116, 2004. ,
DOI : 10.1046/j.1365-2125.2003.01943.x
Current Drug Therapy Recommendations for the Treatment of Attention Deficit Hyperactivity Disorder, Drugs, vol.56, issue.2, pp.215-223, 1998. ,
DOI : 10.2165/00003495-199856020-00005
Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry, pp.944-951, 1999. ,
Growth deficits in ADHD children revisited: evidence for disorderassociated growth delays? J Am Acad Child Adolesc Psychiatry, pp.1460-1469, 1996. ,
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults, New England Journal of Medicine, vol.365, issue.20, pp.1896-1904 ,
DOI : 10.1056/NEJMoa1110212